AZ's Liz Chatwin: Time to be more strategic

March 7, 2018 BioPharmaDispatch Executive Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

In a wide-ranging interview with PharmaDispatch, AstraZeneca's Liz Chatwin talks about how the Australian market has changed, the opportunity for industry to be more strategic on key issues, the importance of manufacturing and R&D, and diversity. …

Subscribe now to continue reading.

Latest Video

US PhRMA puts Australia in the group of innovation free-riders
June 25, 2025 - Latest News
Mark Butler clarifies that the claim of 'quick' PBS listings is limited to this one example
June 25, 2025 - Latest News
Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps
June 25, 2025 - Latest News
MedAdvisor progressing review, including the potential sale of ANZ business
June 27, 2025 - Latest News
AusBiotech leads global engagement to strengthen Australia's life sciences sector
June 25, 2025 - Australian Biotech

AZ's Liz Chatwin: Time to be more strategic

This is a preview of subscriber content

Latest Video

Most Read

US PhRMA puts Australia in the group of innovation free-riders

Mark Butler clarifies that the claim of 'quick' PBS listings is limited to this one example

Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps

MedAdvisor progressing review, including the potential sale of ANZ business

AusBiotech leads global engagement to strengthen Australia's life sciences sector

New Stories

Percheron licenses Phase 2 ready immuno-oncology candidate from Hummingbird

PYC Therapeutics to present progress in Phelan-McDermid Syndrome at global congress

Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule

MedAdvisor progressing review, including the potential sale of ANZ business

Hospital pharmacists use Rare Cancers Awareness Day to call for reform

Mark Butler retains position on critical Cabinet committee

New Zealand to streamline access to ADHD treatments

Sign In

AZ's Liz Chatwin: Time to be more strategic

This is a preview of subscriber content

Latest Video

Most Read

US PhRMA puts Australia in the group of innovation free-riders

Mark Butler clarifies that the claim of 'quick' PBS listings is limited to this one example

Leukaemia Foundation calls for urgent action to address diagnosis and treatment gaps

MedAdvisor progressing review, including the potential sale of ANZ business

AusBiotech leads global engagement to strengthen Australia's life sciences sector

Follow Us

New Stories

Percheron licenses Phase 2 ready immuno-oncology candidate from Hummingbird

PYC Therapeutics to present progress in Phelan-McDermid Syndrome at global congress

Atmo Biosciences receives US FDA clearance for ingestible gas-sensing capsule

MedAdvisor progressing review, including the potential sale of ANZ business

Hospital pharmacists use Rare Cancers Awareness Day to call for reform

Mark Butler retains position on critical Cabinet committee

New Zealand to streamline access to ADHD treatments